The ADVANCE study: A randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1327-1339

  Raggi, Paolo ^a   Chertow, Glenn M ^b   Torres, Pablo Urena ^c   Csiky, Botond ^d   Naso, Agostino ^e   Nossuli, Kaldun ^f   Moustafa, Moustafa ^g   Goodman, William G ^h   Lopez, Nicole ^h   Downey, Gerry ⁱ   Dehmel, Bastian ^h   Floege, Jrgen ^j  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Clinique du Landy   (France)

^d UNIVERSITY OF PÉCS   (Hungary)

^e UNIVERSITY OF PADOVA   (Italy)

^f Washington Nephrology Associates   (United States)

^g South Carolina Nephrology and Hypertension   (United States)

^h AMGEN INC   (United States)

ⁱ AMGEN LTD   (United Kingdom)

^j RWTH AACHEN UNIVERSITY   (Germany)

more..

Author keywords

calcification; cinacalcet; hemodialysis; secondary hyperparathyroidism; vitamin D

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; VITAMIN D;

ADULT; AORTA; AORTA VALVE; ARTICLE; BLOOD VESSEL CALCIFICATION; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPOCALCEMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MONOTHERAPY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; CALCINOSIS; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; VITAMIN D; VITAMINS;

EID: 79953903052     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq725     Document Type: Article

References (45)

1. Kramer H, Toto R, Peshock R et al. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol 2005; 16: 507-513 (Pubitemid 41725148)
2. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401 (Pubitemid 26075849)
3. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483 (Pubitemid 30318271)
4. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications inend-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021 (Pubitemid 30410374)
5. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701 (Pubitemid 34158168)
6. London GM, Guerin AP, MarchaisSJet al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740 (Pubitemid 37098542)
7. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942 (Pubitemid 34258697)
8. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248
9. Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441
10. Moe SM, Chertow GM. The case against calcium-based phosphate binders. Clin J Am Soc Nephrol 2006; 1: 697-703
11. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252 (Pubitemid 34754068)
12. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824 (Pubitemid 43169927)
13. Asmus HG, Braun J, Krause R et al. Two year comparison of seve-lamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 2005; 20: 1653-1661 (Pubitemid 41418591)
14. Bleyer AJ, Burkart J, Piazza M et al. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis 2005; 46: 464-469 (Pubitemid 41208182)
15. Kawata T, Nagano N, Obi M et al. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int 2008; 74: 1270-1277
16. Joki N, Nikolov IG, Caudrillier A et al. Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice. Bone 2009; 45: S30-S34
17. Koleganova N, Piecha G, Ritz E et al. A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 2009; 75: 60-71
18. Lopez I, Aguilera-Tejero E, Mendoza FJ et al. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with cal-citriol. J Am Soc Nephrol 2006; 17: 795-804
19. Fishbane S, Shapiro WB, Corry DB et al. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperpara-thyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol 2008; 3: 1718-1725
20. Block GA, Martin KJ, de Francisco AL et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525 (Pubitemid 38477776)
21. Sprague SM, Llach F, Amdahl M et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003; 63: 1483-1490 (Pubitemid 36350014)
22. Floege J, Raggi P, Block GA et al. Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 1916-1923
23. Bellasi A, Kooienga L, Block GA et al. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? J Nephrol 2009; 22: 255-262
24. Callister TQ, Cooil B, Raya SP et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998; 208: 807-814 (Pubitemid 28405121)
25. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832 (Pubitemid 20101575)
26. Raggi P,Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004; 24: 1272-1277 (Pubitemid 38880020)
27. Chertow GM, Pupim LB, Block GA et al. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol 2007; 2: 898-905
28. Shaw LJ, Raggi P, Schisterman E et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003; 228: 826-833 (Pubitemid 37025495)
29. Taylor AJ, Bindeman J, Feuerstein I et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol 2005; 46: 807-814 (Pubitemid 41224803)
30. Drueke TB, Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 2009; 4: 234-241
31. Schinke T, Karsenty G. Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant 2000; 15: 1272-1274
32. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60: 472-479 (Pubitemid 32680895)
33. Martin KJ, Gonzalez EA, Gellens M et al. 19-Nor-1-alpha-25- dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol 1998; 9: 1427-1432 (Pubitemid 28354552)
34. Bas A, Lopez I, Perez J et al. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006; 21: 484-490
35. ®) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1370-1377 (Pubitemid 41430610)
36. ®) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 2007; 68: 10-17 (Pubitemid 47045487)
37. Raggi P, Bommer J, Chertow GM. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis 2004; 13: 134-141
38. Qunibi W, Moustafa M, Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965 (Pubitemid 351697566)
39. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951 (Pubitemid 38822076)
40. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006; 47: 1027-1034 (Pubitemid 44289155)
41. Nakamura S, Ishibashi-Ueda H, Niizuma S et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900
42. Daniell AL, Wong ND, Friedman JD et al. Concordance of coronary artery calcium estimates between MDCT and electron beam tomography. AJR Am J Roentgenol 2005; 185: 1542-1545
43. Detrano RC, Anderson M, Nelson J et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan re-producibility-MESA study. Radiology 2005; 236: 477-484 (Pubitemid 41023428)
44. Russo D, Corrao S, Miranda I et al. Progression of coronary artery calcification in predialysis patients. Am J Nephrol 2007; 27: 152-158 (Pubitemid 46588180)
45. Razzaque MS, St-Arnaud R, Taguchi T et al. FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant 2005; 20: 2032-2035 (Pubitemid 41510074)